m+Medelevator.RU
← Поиск публикаций
BMC nephrology · 2025

Determinants of dialysis adequacy in maintenance hemodialysis patients: a cross-sectional study on modifiable risk factors and clinical interventions.

СтатьяНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Jia Wanning, He Wenwen, Chen Zhuozhuo, Wang Haiyan, Lu Haitao

Аннотация

BACKGROUND: Dialysis adequacy is crucial for maintaining the health and quality of life of patients undergoing maintenance hemodialysis (MHD). Assessing its current status and identifying influencing factors is essential for optimizing treatment outcomes. We aimed to evaluate the status of dialysis adequacy in MHD patients and analyze the factors that affect it.

METHODS: A cross-sectional study was conducted at a hemodialysis center from June to October 2024. A total of 232 MHD patients were included in the study. Data on demographics, hemodialysis parameters, and laboratory indicators were collected. Dialysis adequacy was assessed using the single pool Kt/V (spKt/V) method. Patients were categorized into adequate (spKt/V ≥ 1.2) and inadequate (spKt/V < 1.2) dialysis groups.

RESULTS: Of the 232 patients, 147 (63.36%) had adequate dialysis. Factors significantly associated with dialysis adequacy included sex, age, dialysis duration, dry weight, vascular access type, ultrafiltration volume, β2-microglobulin levels, and oxygen supplementation (P < 0.05). Multiple linear regression analysis revealed that dialysis duration was an independent protective factor, whereas dry weight was an independent risk factor. These variables accounted for 79.30% of the variance in dialysis adequacy.

CONCLUSIONS: Dialysis adequacy in MHD patients requires further enhancement. Healthcare professionals can improve dialysis adequacy, ensure treatment efficacy, and enhance patients' quality of life by adjusting dry weight, administering continuous low-flow oxygen inhalation during dialysis, and managing interdialytic weight gain.

TRIAL REGISTRATION: Current Controlled Trials ISRCTN13609931, registered on 27 February 2025.

Предметные рубрики MeSH

ИП Урсолов Владлен Сергеевич

ИНН 500118482352 · ОГРНИП 314500117700049

Реквизиты и контакты